English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/157456
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Synthesis, high-throughput screening and pharmacological characterization of β-lactam derivatives as TRPM8 antagonists

AutorTorre-Martínez, Roberto de la; Bonache de Marcos, María Ángeles ; Llabrés-Campaner, P. J.; Balsera, Beatriz; Fernández-Carvajal, Asia; Fernández-Ballester, Gregorio; Pérez de Vega, M. Jesús; González-Muñiz, Rosario
Fecha de publicación2017
EditorNature Publishing Group
CitaciónScientific Reports 7 (2017)
ResumenThe mammalian transient receptor potential melastatin channel 8 (TRPM8), highly expressed in trigeminal and dorsal root ganglia, mediates the cooling sensation and plays an important role in the cold hypersensitivity characteristic of some types of neuropathic pain, as well as in cancer. Consequently, the identification of selective and potent ligands for TRPM8 is of great interest. Here, a series of compounds, having a β-lactam central scaffold, were prepared to explore the pharmacophore requirements for TRPM8 modulation. Structure-activity studies indicate that the minimal requirements for potent β-lactam-based TRPM8 blockers are hydrophobic groups (benzyl preferentially or Bu) on R, R, R and R and a short N-alkyl chain (≤3 carbons). The best compounds in the focused library (41 and 45) showed IC values of 46 nM and 83 nM, respectively, in electrophysiology assays. These compounds selectively blocked all modalities of TRPM8 activation, i.e. menthol, voltage, and temperature. Molecular modelling studies using a homology model of TRPM8 identified two putative binding sites, involving networks of hydrophobic interactions, and suggesting a negative allosteric modulation through the stabilization of the closed state. Thus, these β-lactams provide a novel pharmacophore scaffold to evolve TRPM8 allosteric modulators to treat TRPM8 channel dysfunction.
Versión del editorhttp://dx.doi.org/10.1038/s41598-017-10913-x
URIhttp://hdl.handle.net/10261/157456
DOI10.1038/s41598-017-10913-x
Identificadoresdoi: 10.1038/s41598-017-10913-x
issn: 2045-2322
e-issn: 2045-2322
Aparece en las colecciones: (IQM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Scientific REPOrTS10766.pdf1,86 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.